<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04793841</url>
  </required_header>
  <id_info>
    <org_study_id>CID-CUHK-E</org_study_id>
    <nct_id>NCT04793841</nct_id>
  </id_info>
  <brief_title>Population Burden of STI and Implication for Intervention in Hong Kong</brief_title>
  <official_title>Population Burden of Sexually Transmitted Infections and Implication for Intervention in Hong Kong</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese University of Hong Kong</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a 5-year cross-disciplinary sexually transmitted infection (STI) project involving a)&#xD;
      territory-wide and community-based studies (survey and specimen collection); b) simulation of&#xD;
      STI transmission dynamics and comparison of STI intervention strategies through mathematical&#xD;
      modelling and cost-effectiveness analysis. The aim of this project is to assess the burden&#xD;
      and the transmission dynamics of STIs in the general population and men who have sex with men&#xD;
      (MSM) in Hong Kong. Around 1300 sexually experienced adults and 900 MSM would be recruited,&#xD;
      100 participants would be invited for individual in-depth interviews. Main outcome measures&#xD;
      include STI history and service preference, effectiveness as measured by the proportion of&#xD;
      new STI infections (chlamydia, gonorrhoea and human papillomavirus infections) averted above&#xD;
      base-case scenario, and incremental cost-effectiveness ratio.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After completion of baseline questionnaire, the participants are invitied for STI&#xD;
      self-sampling. If agree, a package of self-sampling kits, instructions, and packaging&#xD;
      materials for return post would be delivered to their selected collection points. The second&#xD;
      round of self-sampling would be offered at least one year from the first round of&#xD;
      self-sampled specimens collected.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 13, 2021</start_date>
  <completion_date type="Anticipated">September 30, 2025</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>self-reported STI diagnosis in questionnaire</measure>
    <time_frame>up to 2 years</time_frame>
    <description>number of STI diagnosis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>effectiveness of STI intervention strategies</measure>
    <time_frame>10 years</time_frame>
    <description>incremental cost-effectiveness ratio</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>STI symptom reported in questionnaire</measure>
    <time_frame>12 months</time_frame>
    <description>types of symptom presentations</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>willingness to pay for STI testing reported in questionnaire</measure>
    <time_frame>12 months</time_frame>
    <description>willingness to pay (HKD)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>prevalence of STI estimated through laboratory testing</measure>
    <time_frame>12 months</time_frame>
    <description>prevalence of chlamydia trachomatis, Neisseria gonorrhoeae and human papillomavirus infections from self-collected samples</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">2200</enrollment>
  <condition>STI</condition>
  <arm_group>
    <arm_group_label>General population</arm_group_label>
    <description>sexually experienced adults (aged 18 or above) of the randomly selected household</description>
  </arm_group>
  <arm_group>
    <arm_group_label>men who have sex with men</arm_group_label>
    <description>men who have sex with men aged 18 or above and normally living in Hong Kong</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>self-sampling kits for STI testing in laboratory</intervention_name>
    <description>participants in both groups will receive self-sampling kits and deliver the collected samples to laboratory for testing</description>
    <arm_group_label>General population</arm_group_label>
    <arm_group_label>men who have sex with men</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      urine, penile swab, cervical swab, rectal swab, pharyngeal swab&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        sexually experienced adults&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  aged 18 or above&#xD;
&#xD;
          -  ever having sex&#xD;
&#xD;
          -  normally living in Hong Kong&#xD;
&#xD;
          -  can communicate in English or Chinese&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  failed to provide consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ngai Sze Wong, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chinese University of Hong Kong</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ngai Sze Wong, PhD</last_name>
    <phone>(852)22528862</phone>
    <email>candy_wong@cuhk.edu.hk</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Chinese University of Hong Kong</name>
      <address>
        <city>Hong Kong</city>
        <state>Hong Kong, China</state>
        <zip>0000</zip>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ngai Sze Wong, PhD</last_name>
      <phone>22528862</phone>
      <email>candy_wong@cuhk.edu.hk</email>
    </contact>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>February 1, 2021</study_first_submitted>
  <study_first_submitted_qc>March 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 11, 2021</study_first_posted>
  <last_update_submitted>August 2, 2021</last_update_submitted>
  <last_update_submitted_qc>August 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese University of Hong Kong</investigator_affiliation>
    <investigator_full_name>Ngai Sze WONG</investigator_full_name>
    <investigator_title>Research Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>chlamydia trachomatis</keyword>
  <keyword>Neisseria gonorrhoeae</keyword>
  <keyword>human papillomavirus</keyword>
  <keyword>men who have sex with men</keyword>
  <keyword>general population</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

